TCL Archive Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy May 30, 2014
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980